发明名称 ALPHA-2 ADRENERGIC AGONIST FOR TREATING INTRAOCULAR PRESSURE AND OCULAR DISEASES THROUGH INTRAVITREAL AND INTRACAMERAL ROUTES
摘要 The present invention provides a method of lowering intraocular pressure which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin-2-ylamino)benzimidazole, or a salt thereof to the affected eye of a patient, as a single dose, wherein the affected eye has an intraocular pressure less than the baseline.
申请公布号 US2014275197(A1) 申请公布日期 2014.09.18
申请号 US201414206746 申请日期 2014.03.12
申请人 Allergan, Inc. 发明人 DIBAS Mohammed I.;GIL Daniel W.;DONELLO John E.
分类号 A61K31/4184;A61K9/00 主分类号 A61K31/4184
代理机构 代理人
主权项 1. A method of lowering intraocular pressure which comprises administering by direct injection into the eye a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin2-ylamino)benzimidazole or a salt thereof, to the affected eye of a patient, in need thereof, as a single dose.
地址 Irvine CA US